Skip to main content

Fexofenadine HCl and Pseudoephedrine HCl

NDC 0363-0049 · Walgreens company

FDA lists marketing as ended on 2026-08-30.
Generic nameFexofenadine HCl and Pseudoephedrine HCl
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE
Strength180; 240 mg/1; mg/1
Pharmacologic classAdrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
Marketing categoryANDA

Packages

0363-0049-10 — 2 BLISTER PACK in 1 CARTON (0363-0049-10) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0113-0432 — Pseudoephedrine HCl, 0113-0847 — fexofenadine hydrochloride, 0113-2017 — Pseudoephedrine HCl, 0113-2147 — Cetirizine hydrochloride, Pseudoephedrine hydrochloride, 0113-8307 — guaifenesin and pseudoephedrine hydrochloride, 0113-8911 — guaifenesin, pseudoephedrine hydrochloride, 0121-0933 — Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide, 0280-6045 — naproxen sodium, pseudoephedrine hydrochloride, 0280-6090 — naproxen sodium, pseudeoephedrine hydrochloride, 0363-0044 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 0363-0077 — Guaifenesin and Pseudoephedrine Hydrochloride, 0363-0094 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 0363-0134 — Guaifenesin and Pseudoephedrine HCl, 0363-0204 — Pseudoephedrine Hydrochloride, 0363-0287 — Pseudoephedrine HCl, Triprolidine HCl, 0363-0423 — Ibuprofen and Pseudoephedrine Hydrochloride, 0363-0650 — Naproxen sodium, Pseudoephedrine HCl, 0363-0783 — Fexofenadine hydrochloride, 0363-0784 — Fexofenadine hydrochloride, 0363-0989 — Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride, +483 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels